You are here:
HomeProductsGSK1904529A;GSK 1904529A;GSK-1904529A
GSK1904529A;GSK 1904529A;GSK-1904529A
Detailed Description
GSK1904529A, which potently inhibits IGF-IR (IC50= 27 nmol/L) and IR (IC50= 25 nmol/L) activities in vitro and in vivo, is a promising candidate for therapeutic use in solid and hematologic cancers.
http://www.chemscene.com/GSK1904529A.html